Clinical Trial Update: Effects of Tildrakizumab on Epigenetic Age [Phase 4]

View source ↗

Summary

Phase 4 clinical trial assessing the effect of tildrakizumab on epigenetic age in patients with psoriasis; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Tildrakizumab (tildrakizumab)

Snippet

Sponsor: Carlos Wambier | Conditions: Psoriasis, Aging | Phase 4 | Status: COMPLETED